Transaction log
Feb 18, 2020 - Bought 10 @ $397.65 (3.98% wtg, coffee can)
Jun 10, 2020 - Sold 2 @ $611.80 (8 shares, 4.19% wtg)
Feb 8, 2021 - Bought 2 @ $497.62 (10 shares, 3.40% wtg)
Sep 7, 2023 - Sold 2 @ $820.09 (8 shares, 4.18% wtg)
Jul 1, 2024 - Sold 1 @ $1,067.86 (7 shares, 4.17% wtg)
Aug 27, 2025 - Upgraded to coffee can innovators
Regeneron Pharmaceuticals
Location: Tarrytown, New York
Estimated fair value history
Mar-25 - $1,097 (20 x R&D)
Jun-25 - $1,161
Sep-25 - $1,220
Dec-25 - $1,254
Mar-26 - $1,180 (18 x R&D)
Jun-26 - $1,230
Profile
Symbol: REGN
Industry: Biotechnology
Sector: Health care
Theme: Genomic revolution
Annual gross profit: $13.2 billion
5-year gross profit growth: +10.1%/year
5-Year shareholder growth: +14.4%/year
Estimated fair value: $1,230
Valuation assumption: 18 x annual R&D
Operating income/gross profit: 31.6%
Insider ownership: 6.9%
Investments: Alnylam Pharmaceuticals (ALNY), Intellia Therapeutics (NTLA)
